Matsuoka Saori, Dam Elisabeth, Lecossier Denise, Clavel François, Hance Allan J
INSERM U941, Paris 75010, France.
Retrovirology. 2009 Mar 2;6:21. doi: 10.1186/1742-4690-6-21.
HIV-1 Gag proteins are essential for virion assembly and viral replication in newly infected cells. Gag proteins are also strong determinants of viral infectivity; immune escape mutations in the Gag capsid (CA) protein can markedly reduce viral fitness, and interactions of CA with host proteins such as cyclophilin A (CypA) and TRIM5alpha can have important effects on viral infectivity. Little information, however, is available concerning the extent that different primary Gag proteins affect HIV-1 replication in different cell types, or the impact on viral replication of differences in the expression by target cells of proteins that interact with CA. To address these questions, we compared the infectivity of recombinant HIV-1 viruses expressing Gag-protease sequences from primary isolates in different target cells in the presence or absence of agents that disrupt cyclophilin A - CA interactions and correlated these results with the viral genotype and the expression of cyclophilin A and TRIM5alpha by the target cells.
Viral infectivity was governed by the nature of the Gag proteins in a target cell-specific fashion. The treatment of target cells with agents that disrupt CypA-CA interactions often produced biphasic dose-response curves in which viral infectivity first increased and subsequently decreased as a function of the dose used. The extent that treatment of target cells with high-dose CypA inhibitors impaired viral infectivity was dependent on several factors, including the viral genotype, the nature of the target cell, and the extent that treatment with low-dose CypA inhibitors increased viral infectivity. Neither the presence of polymorphisms in the CA CypA-binding loop, the level of expression of CypA, or the level of TRIM5alpha expression could, alone, explain the differences in the shape of the dose-response curves observed or the extent that high-dose CypA inhibitors reduced viral infectivity.
Multiple interactions between host-cell factors and Gag can strongly affect HIV-1 infectivity, and these vary according to target cell type and the origin of the Gag sequence. Two of the cellular activities involved appear to be modulated in opposite directions by CypA-CA interactions, and Gag sequences determine the intrinsic sensitivity of a given virus to each of these cellular activities.
HIV-1 Gag蛋白对于病毒体组装以及新感染细胞中的病毒复制至关重要。Gag蛋白也是病毒感染性的重要决定因素;Gag衣壳(CA)蛋白中的免疫逃逸突变可显著降低病毒适应性,并且CA与亲环素A(CypA)和TRIM5α等宿主蛋白的相互作用可对病毒感染性产生重要影响。然而,关于不同的初级Gag蛋白在何种程度上影响HIV-1在不同细胞类型中的复制,或者与CA相互作用的蛋白在靶细胞中的表达差异对病毒复制的影响,目前所知甚少。为了解决这些问题,我们比较了表达来自原发性分离株的Gag蛋白酶序列的重组HIV-1病毒在不同靶细胞中的感染性,这些靶细胞存在或不存在破坏亲环素A - CA相互作用的试剂,并将这些结果与病毒基因型以及靶细胞中亲环素A和TRIM5α的表达相关联。
病毒感染性以靶细胞特异性方式受Gag蛋白性质的支配。用破坏CypA-CA相互作用的试剂处理靶细胞通常会产生双相剂量反应曲线,其中病毒感染性首先增加,随后随着所用剂量的增加而降低。高剂量CypA抑制剂处理靶细胞对病毒感染性的损害程度取决于几个因素,包括病毒基因型、靶细胞的性质以及低剂量CypA抑制剂处理增加病毒感染性的程度。CA CypA结合环中的多态性的存在、CypA的表达水平或TRIM5α的表达水平,单独都无法解释所观察到的剂量反应曲线形状的差异或高剂量CypA抑制剂降低病毒感染性的程度。
宿主细胞因子与Gag之间的多种相互作用可强烈影响HIV-1感染性,并且这些相互作用因靶细胞类型和Gag序列的来源而异。所涉及的两种细胞活性似乎通过CypA-CA相互作用在相反方向上受到调节,并且Gag序列决定了给定病毒对每种细胞活性的内在敏感性。